Evidence map›Paper›PMID 41917340›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Existing challenges in the management of cholangiocarcinoma in Spain.

Andrés Jesús Muñoz Martín, Angela Lamarca, Jesus M Banales, Mar Iglesias, Teresa Macarulla

Abstract readEditorial
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrés Jesús Muñoz MartínDepartment of Medical Oncology, Hospital General Universitario Gregorio Marañón, Universidad Complutense, C/Doctor Esquerdo 46, 28007, Madrid, Spain. andmun13@ucm.es.ORCID http://orcid.org/0000-0001-6977-8249
Angela LamarcaDepartment of Medical Oncology, Hospital Universitario Fundación Jimenez Díaz, Madrid, Spain.ORCID http://orcid.org/0000-0001-9696-6122
Jesus M BanalesDepartment of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute - Donostia University Hospital, CIBERehd, Ikerbasque, San Sebastian, Spain.ORCID http://orcid.org/0000-0002-5224-2373
Mar IglesiasDepartment of Pathology, Hospital del Mar. Hospital del Mar Research Institute. University Pompeu Fabra, Barcelona, Spain.ORCID http://orcid.org/0000-0002-2274-4671
Teresa MacarullaMedical Oncology Department, Hospital Clinic Barcelona, Translational Oncology in Upper Gastrointestinal Cancer Group, IDIBAPS, Barcelona, Spain.ORCID http://orcid.org/0000-0002-5856-4082

Funding

Servier España EditorialServier España Medical Writing Support
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.